Skip to main content
Erschienen in: International Journal of Colorectal Disease 7/2009

01.07.2009 | Original Article

Prognostic impact of intrahepatic lymphatic and microvascular involvement in cases of colorectal liver metastases

verfasst von: Maximilian Bockhorn, Georgios Sotiropoulos, Jan Neuhaus, George Sgourakis, Sien-Yi Sheu, Ernesto Molmenti, Christian Fingas, Tanja Trarbach, Andreja Frilling, Christoph E. Broelsch

Erschienen in: International Journal of Colorectal Disease | Ausgabe 7/2009

Einloggen, um Zugang zu erhalten

Abstract

Objective

The purpose of this study was to evaluate the effect of intrahepatic microvascular and lymphatic infiltration on survival in cases of colorectal liver metastases.

Materials and methods

Prospectively collected data of 331 patients were analyzed for microvascular invasion (V), lymphatic infiltration (L), and resection margins (R) with respect to overall and disease-free survival.

Results

One-, 3-, and 5-year overall survival rates for R0 resected patients were 89%, 64%, and 39%, respectively. The corresponding survival rates for R1 resected patients were 83%, 42%, and 24% (p < 0.001). The sole presence of microvascular invasion (V1) or lymphatic infiltration (L1) was not associated with a diminished overall survival (p > 0.05). However, patients with a combination of L1V1 had a significantly worse overall survival of 68%, 20%, and 0% when compared to L0V0 patients. This difference was not influenced by the status of the resection margin. No other parameter investigated was found to be of predictive value.

Conclusions

The presence of combined lymphatic and vascular invasion (L1V1) constitutes a predictor of poor overall and disease-free survival. This subgroup of patients might benefit from adjuvant strategies such as chemotherapeutic treatment.
Literatur
1.
Zurück zum Zitat Belli G, D'Agostino A, Ciciliano F et al (2002) Liver resection for hepatic metastases: 15 years of experience. J Hepatobiliary Pancreat Surg 9:607–613PubMedCrossRef Belli G, D'Agostino A, Ciciliano F et al (2002) Liver resection for hepatic metastases: 15 years of experience. J Hepatobiliary Pancreat Surg 9:607–613PubMedCrossRef
2.
Zurück zum Zitat Bodingbauer M, Tamandl D, Schmid K et al (2007) Size of surgical margin does not influence recurrence rates after curative liver resection for colorectal cancer liver metastases. Br J Surg 94:1133–1138PubMedCrossRef Bodingbauer M, Tamandl D, Schmid K et al (2007) Size of surgical margin does not influence recurrence rates after curative liver resection for colorectal cancer liver metastases. Br J Surg 94:1133–1138PubMedCrossRef
3.
Zurück zum Zitat DeMatteo RP, Fong Y, Blumgart LH (1999) Surgical treatment of malignant liver tumours. Baillieres Best Pract Res Clin Gastroenterol 13:557–574PubMedCrossRef DeMatteo RP, Fong Y, Blumgart LH (1999) Surgical treatment of malignant liver tumours. Baillieres Best Pract Res Clin Gastroenterol 13:557–574PubMedCrossRef
4.
Zurück zum Zitat Fusai G, Davidson BR (2003) Management of colorectal liver metastases. Colorectal Dis 5:2–23PubMedCrossRef Fusai G, Davidson BR (2003) Management of colorectal liver metastases. Colorectal Dis 5:2–23PubMedCrossRef
5.
Zurück zum Zitat van de Velde CJ (2005) Treatment of liver metastases of colorectal cancer. Ann Oncol 16(Suppl 2):ii144–ii119PubMedCrossRef van de Velde CJ (2005) Treatment of liver metastases of colorectal cancer. Ann Oncol 16(Suppl 2):ii144–ii119PubMedCrossRef
6.
Zurück zum Zitat Fong Y, Fortner J, Sun RL et al (1999) Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230:309–318PubMedCrossRef Fong Y, Fortner J, Sun RL et al (1999) Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230:309–318PubMedCrossRef
7.
Zurück zum Zitat Scheele J, Altendorf-Hofmann A, Stangl R, Schmidt K (1996) Surgical resection of colorectal liver metastases: gold standard for solitary and radically resectable lesions. Swiss Surg 4:4–17PubMed Scheele J, Altendorf-Hofmann A, Stangl R, Schmidt K (1996) Surgical resection of colorectal liver metastases: gold standard for solitary and radically resectable lesions. Swiss Surg 4:4–17PubMed
8.
Zurück zum Zitat Biasco G, Derenzini E, Grazi G et al (2006) Treatment of hepatic metastases from colorectal cancer: many doubts, some certainties. Cancer Treat Rev 32:214–228PubMedCrossRef Biasco G, Derenzini E, Grazi G et al (2006) Treatment of hepatic metastases from colorectal cancer: many doubts, some certainties. Cancer Treat Rev 32:214–228PubMedCrossRef
9.
Zurück zum Zitat Choti MA, Sitzmann JV, Tiburi MF et al (2002) Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 235:759–766PubMedCrossRef Choti MA, Sitzmann JV, Tiburi MF et al (2002) Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 235:759–766PubMedCrossRef
10.
Zurück zum Zitat Minagawa M, Makuuchi M, Torzilli G et al (2000) Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results. Ann Surg 231:487–499PubMedCrossRef Minagawa M, Makuuchi M, Torzilli G et al (2000) Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results. Ann Surg 231:487–499PubMedCrossRef
11.
Zurück zum Zitat Gayowski TJ, Iwatsuki S, Madariaga JR et al (1994) Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery 116:703–710PubMed Gayowski TJ, Iwatsuki S, Madariaga JR et al (1994) Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery 116:703–710PubMed
12.
Zurück zum Zitat Liu LX, Zhang WH, Jiang HC (2003) Current treatment for liver metastases from colorectal cancer. World J Gastroenterol 9:193–200PubMed Liu LX, Zhang WH, Jiang HC (2003) Current treatment for liver metastases from colorectal cancer. World J Gastroenterol 9:193–200PubMed
13.
Zurück zum Zitat Tanaka K, Shimada H, Matsuo K et al (2004) Outcome after simultaneous colorectal and hepatic resection for colorectal cancer with synchronous metastases. Surgery 136:650–659PubMedCrossRef Tanaka K, Shimada H, Matsuo K et al (2004) Outcome after simultaneous colorectal and hepatic resection for colorectal cancer with synchronous metastases. Surgery 136:650–659PubMedCrossRef
14.
Zurück zum Zitat Pawlik TM, Scoggins CR, Zorzi D et al (2005) Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg 241:715–712PubMedCrossRef Pawlik TM, Scoggins CR, Zorzi D et al (2005) Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg 241:715–712PubMedCrossRef
15.
Zurück zum Zitat Sasaki A, Aramaki M, Kawano K et al (2002) Prognostic significance of intrahepatic lymphatic invasion in patients with hepatic resection due to metastases from colorectal carcinoma. Cancer 95:105–111PubMedCrossRef Sasaki A, Aramaki M, Kawano K et al (2002) Prognostic significance of intrahepatic lymphatic invasion in patients with hepatic resection due to metastases from colorectal carcinoma. Cancer 95:105–111PubMedCrossRef
16.
Zurück zum Zitat DeOliveira ML, Cunningham SC, Cameron JL et al (2007) Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg 245:755–762PubMedCrossRef DeOliveira ML, Cunningham SC, Cameron JL et al (2007) Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg 245:755–762PubMedCrossRef
17.
Zurück zum Zitat Nakajima T, Kondo Y, Miyazaki M, Okui K (1988) A histopathologic study of 102 cases of intrahepatic cholangiocarcinoma: histologic classification and modes of spreading. Hum Pathol 19:1228–1234PubMedCrossRef Nakajima T, Kondo Y, Miyazaki M, Okui K (1988) A histopathologic study of 102 cases of intrahepatic cholangiocarcinoma: histologic classification and modes of spreading. Hum Pathol 19:1228–1234PubMedCrossRef
18.
Zurück zum Zitat Korita PV, Wakai T, Shirai Y et al (2007) Intrahepatic lymphatic invasion independently predicts poor survival and recurrences after hepatectomy in patients with colorectal carcinoma liver metastases. Ann Surg Oncol 14:3472–3480PubMedCrossRef Korita PV, Wakai T, Shirai Y et al (2007) Intrahepatic lymphatic invasion independently predicts poor survival and recurrences after hepatectomy in patients with colorectal carcinoma liver metastases. Ann Surg Oncol 14:3472–3480PubMedCrossRef
19.
Zurück zum Zitat Bockhorn M, Jain RK, Munn LL (2007) Active versus passive mechanisms in metastasis: do cancer cells crawl into vessels, or are they pushed? Lancet Oncol 8:444–448PubMedCrossRef Bockhorn M, Jain RK, Munn LL (2007) Active versus passive mechanisms in metastasis: do cancer cells crawl into vessels, or are they pushed? Lancet Oncol 8:444–448PubMedCrossRef
20.
Zurück zum Zitat Nagashima I, Takada T, Matsuda K et al (2004) A new scoring system to classify patients with colorectal liver metastases: proposal of criteria to select candidates for hepatic resection. J Hepatobiliary Pancreat Surg 11:79–83PubMedCrossRef Nagashima I, Takada T, Matsuda K et al (2004) A new scoring system to classify patients with colorectal liver metastases: proposal of criteria to select candidates for hepatic resection. J Hepatobiliary Pancreat Surg 11:79–83PubMedCrossRef
21.
Zurück zum Zitat Nordlinger B, Guiguet M, Vaillant JC et al (1996) Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie. Cancer 77:1254–1262PubMedCrossRef Nordlinger B, Guiguet M, Vaillant JC et al (1996) Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie. Cancer 77:1254–1262PubMedCrossRef
22.
Zurück zum Zitat Ueno H, Mochizuki H, Hashiguchi Y et al (2004) Predictors of extrahepatic recurrence after resection of colorectal liver metastases. Br J Surg 91:327–333PubMedCrossRef Ueno H, Mochizuki H, Hashiguchi Y et al (2004) Predictors of extrahepatic recurrence after resection of colorectal liver metastases. Br J Surg 91:327–333PubMedCrossRef
23.
Zurück zum Zitat Parks R, Gonen M, Kemeny N et al (2007) Adjuvant chemotherapy improves survival after resection of hepatic colorectal metastases: analysis of data from two continents. J Am Coll Surg 204:753–761PubMedCrossRef Parks R, Gonen M, Kemeny N et al (2007) Adjuvant chemotherapy improves survival after resection of hepatic colorectal metastases: analysis of data from two continents. J Am Coll Surg 204:753–761PubMedCrossRef
24.
Zurück zum Zitat Cady B, McDermott WV (1985) Major hepatic resection for metachronous metastases from colon cancer. Ann Surg 201:204–209PubMedCrossRef Cady B, McDermott WV (1985) Major hepatic resection for metachronous metastases from colon cancer. Ann Surg 201:204–209PubMedCrossRef
25.
Zurück zum Zitat Liska V, Treska V, Holubec L et al (2007) Recurrence of colorectal liver metastases after surgical treatment: multifactorial study. Hepatogastroenterology 54:1741–1744PubMed Liska V, Treska V, Holubec L et al (2007) Recurrence of colorectal liver metastases after surgical treatment: multifactorial study. Hepatogastroenterology 54:1741–1744PubMed
26.
Zurück zum Zitat Kohne CH, Folprecht G (2004) Current perspectives in the treatment of metastatic colorectal cancer. Ann Oncol Suppl 4:iv43–iv53 Kohne CH, Folprecht G (2004) Current perspectives in the treatment of metastatic colorectal cancer. Ann Oncol Suppl 4:iv43–iv53
27.
Zurück zum Zitat McCarthy M (2003) Antiangiogenesis drug promising for metastatic colorectal cancer. Lancet 361:1959PubMedCrossRef McCarthy M (2003) Antiangiogenesis drug promising for metastatic colorectal cancer. Lancet 361:1959PubMedCrossRef
Metadaten
Titel
Prognostic impact of intrahepatic lymphatic and microvascular involvement in cases of colorectal liver metastases
verfasst von
Maximilian Bockhorn
Georgios Sotiropoulos
Jan Neuhaus
George Sgourakis
Sien-Yi Sheu
Ernesto Molmenti
Christian Fingas
Tanja Trarbach
Andreja Frilling
Christoph E. Broelsch
Publikationsdatum
01.07.2009
Verlag
Springer-Verlag
Erschienen in
International Journal of Colorectal Disease / Ausgabe 7/2009
Print ISSN: 0179-1958
Elektronische ISSN: 1432-1262
DOI
https://doi.org/10.1007/s00384-009-0674-6

Weitere Artikel der Ausgabe 7/2009

International Journal of Colorectal Disease 7/2009 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.